切换导航
关闭
  • 菜单
  • Setting

Signaling Pathways - Immunological Diseases - Pancreatic Carcinoma - Schizophrenia - Leukemia

52件产品中的 1-10

页面
每页
清除全部
  1. 5-BrdU
    B3589 5-BrdU
    中文名: 溴尿苷
    Summary: 胸腺嘧啶核苷类似物
      ≥15.35 mg/mL
      ≥16.23 mg/mL
  2. Chlorpromazine HCl
    B1480 Chlorpromazine HCl
    中文名: 盐酸氯丙嗪
    Summary: 多巴胺拮抗剂
      ≥17.77 mg/mL
      ≥71.4 mg/mL
  3. Pergolide mesylate
    B1485 Pergolide mesylate
    中文名: 甲磺酸培高利特
    Target: D1 and D5 Receptors|D2 Receptors
    Summary: 多巴胺能激动剂
      ≥6.84 mg/mL
      insoluble in H2O
  4. C646
    B1577 C646
     1 Citation
    Target: p300
    Summary: HAT p300-CBP抑制剂
      ≥11.14 mg/mL
      insoluble in H2O
  5. Amitriptyline HCl
    B2231 Amitriptyline HCl
    中文名: 盐酸阿米替林
    Target: Trk Receptors|5-HT2 Receptors|Norepinephrine transporter|5-HT Transporters
    Summary: 血清素/去甲肾上腺素受体/5-HT4/5-HT2抑制剂
      ≥15.69 mg/mL
      ≥43.9 mg/mL
  6. Lurasidone HCl
    B1477 Lurasidone HCl
    中文名: 盐酸鲁拉西酮
    Target: 5-HT2 Receptors|D2 Receptors|5-HT1 Receptors|5-HT7 Receptors
    Summary: 多巴胺D2/5-HT2A/5-HT7/5-HT1A抑制剂
      ≥11.11 mg/mL
      insoluble in H2O
  7. Quetiapine Fumarate
    B1490 Quetiapine Fumarate
     1 Citation
    中文名: 富马酸奎硫平
    Target: 5-HT2 Receptors|D1 and D5 Receptors|D2 Receptors|D3 Receptors|5-HT1 Receptors|5-HT7 Receptors
    Summary: 多巴胺受体拮抗剂
      ≥11.03 mg/mL
      insoluble in H2O
  8. MLN4924
    B1036 MLN4924
     5 Citation
    Target: NAE|Ubiquitin-activating Enzyme E1|SUMOylation
    Summary: NAE抑制剂
      ≥22.18 mg/mL
      insoluble in H2O
  9. Loxapine
    B1001 Loxapine
     1 Citation
    中文名: 洛沙平
    Target: 5-HT2 Receptors
    Summary: 5-HT受体拮抗剂
      ≥55.6 mg/mL
      <2.78 mg/mL
  10. Aripiprazole
    B2232 Aripiprazole
    中文名: 阿立哌唑
    Target: 5-HT1 Receptors
    Summary: 5-HT受体部分激动剂
      ≥22.4 mg/mL
      insoluble in H2O

52件产品中的 1-10

页面
每页